Abstract
Our knowledge of carcinogenesis has tremendously improved through decades of research. However, till date the therapeutic refractoriness and tumor dormancy that leads to cancer recurrence after therapy presents formidable obstacles through severely limiting the successful treatment outcomes for majority of cancers. Significant advances made recently in the cancer stem cell (CSC) biology field have provided new insights into cancer biology that are radically changing both our understanding of carcinogenesis and cancer treatment. The cancer stem cell hypothesis provides an attractive cellular mechanism to account for the therapeutic refractoriness and dormant behavior exhibited by many of these tumors. Direct evidence for the CSC hypothesis has recently emerged through their identification and isolation in diverse tumor types. These tumor types appeared to be hierarchically organized and sustained by a distinct fraction of self-renewing and tumor-initiating CSCs. Such illustration of the CSC paradigm in diverse tumor types necessitates reassessment and improvisation of the current therapeutic strategies originally developed against the homogenous tumor mass; now to specifically target the CSC population. Preliminary findings in the field indicate that such specific targeting of CSCs may be possible.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CSCs:
-
Cancer stem cells
- EMT:
-
Epithelial to mesenchymal transition
- LRCs:
-
Label retaining cells
- MDR:
-
Multidrug resistance
- NOD/SCID:
-
Non-obese diabetic/severe combined immunodeficient
- NSCs:
-
Normal stem cells, HSCs, hematopoetic stem cells
- RB:
-
Retinoblastoma
- SP:
-
Side population
References
Aguirre-Ghiso J (2007) Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 7: 834–846.
Ajioka I, Martins R, Bayazitov I et al (2007) Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice. Cell 131:378–390.
Al-Hajj M, Wicha M, Benito-Hernandez A et al (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983–3988.
Antunez J, Couce M, Fraga M et al (1991) Immunohistochemical demonstration of neuronal and astrocytic markers and oncofoetal antigens in retinoblastomas. Histol Histopathol 6:241–246.
Balla M, Vemuganti G, Kannabiran C et al (2009) Phenotypic characterization of retinoblastoma for the presence of putative cancer stem-like cell markers by flow cytometry. Invest Ophthalmol Vis Sci 50:1506–1514.
Bapat S ed (2009) Cancer stem cells. Wiley, New Jersey.
Bapat S, Mali A, Koppikar C et al (2005) Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 65:3025–3029.
Bhattacharya S, Jackson J, Das A et al (2003) Direct identification and enrichment of retinal stem cells/progenitors by hoechst dye efflux assay. Invest Ophthalmol Vis Sci 44:2764–2773.
Blanpain C, Lowry W, Geoghegan A et al (2004) Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 118: 635–648.
Bonnet D, Dick J (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730–737.
Calabrese C, Poppleton H, Twala K (2007) Perivascular niche for brain tumor stem cells. Cancer Cell 11: 69–82.
Challen G, Little M (2006) A side order of stem cells: The sp phenotype. Stem Cells 24:3–12.
Chiba T, Kita K, Zheng Y et al (2006) Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 44:240–251.
Cobaleda C, Gutierrez-Cianca N, Perez-Losada J et al (2000) A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia. Blood 95:1007–1013.
Collins A, Berry P, Hyde C, Stower M et al (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65:10946–10951.
Courtenay V, Mills J (1978) An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. Br J Cancer 37:261–268.
Courtenay V, Selby P, Smith I (1978) Growth of human tumor cell colonies from biopsies using two soft-agar techniques. Br J Cancer 38:77–81.
Craft J, Sang D, Dryja T et al (1985) Glial cell component in retinoblastoma. Exp Eye Res 40:647–659.
Decraene C, Benchaouir R, Dillies M et al (2005) Global transcriptional characterization of sp and mp cells from the myogenic c2c12 cell line: Effect of fgf6. Physiol Genom 23:132–149.
Duncan A, Rattis F, DiMascio L et al (2005) Integration of notch and wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 6:314–322.
Eylerand C, Rich J (2008) Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis. J Clin Oncol 26(17): 2839–2845.
Fearon E, Hamilton S, Vogelstein B (1987) Clonal analysis of human colorectal tumors. Science 238: 193–197.
Fialkow P (1976) Clonal origin of human tumors. Biochim. Biophys. Acta 458: 283–321.
Goodell M, Brose K, Paradis G et al (1996) Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183:1797–1806.
Grichnik J, Burch J, Schulteis R et al (2006) Melanoma, a tumor based on a mutant stem cell? J Invest Dermatol 126:142–153.
Hamburger A, Salmon S (1977) Primary bioassay of human tumor stem cells. Science 197: 461.
Hewitt H (1958) Studies of the Dissemination and Quantitative Transplantation of a Lymphocytic Leukaemia of CBA Mice. Br J Cancer 12(3):378–401.
Hirschmann-Jax C, Foster A, Wulf G et al (2004) A distinct “Side population” of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101:14228–14233.
Hopfer O, Zwahlen D, Fey M et al (2005) The notch pathway in ovarian carcinomas and adenomas. Br J Cancer 93:709–718.
Jordan C, Guzman M, Noble M (2006) Cancer stem cells. N Engl J Med 355:1253–1261.
Katano M (2005) Hedgehog signaling pathway as a therapeutic target in breast cancer. Cancer Lett 227:99–104.
Kim C, Jackson E, Woolfenden A et al (2005) Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121:823–835.
Kiran V, Kannabiran C, Chakravarthi K et al (2003) Mutational screening of the rb1 gene in indian patients with retinoblastoma reveals eight novel and several recurrent mutations. Hum Mutat 22:339.
Kivela T (1986) S-100 protein in retinoblastoma revisited. An immunohistochemical study. Acta Ophthalmol (Copenh) 64:664–673.
Kivela T, Virtanen I (1986) Intermediate filaments in the human retina and retinoblastoma. An immunohistochemical study of vimentin, glial fibrillary acidic protein, and neurofilaments. Invest Ophthalmol Vis Sci 27:1075–1084.
Knudson A (1971) Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820–823.
Kolligs F, Bommer G, Goke B (2002) Wnt/beta-catenin/tcf signaling: A critical pathway in gastrointestinal tumorigenesis. Digestion 66:131–144.
Kondo T, Setoguchi T, Taga T (2004) Persistence of a small subpopulation of cancer stem-like cells in the c6 glioma cell line. Proc Natl Acad Sci USA 101:781–786.
Krishnakumar S, Mallikarjuna K, Desai N et al (2004) Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma. Br J Ophthalmol 88:1521–1526.
Krivtsov A, Twomey D, Feng Z (2006) Transformation from committed progenitor to leukaemia stem cell initiated by mll-af9. Nature 442:818–822.
Kruh G (2003) Introduction to resistance to anticancer agents. Oncogene 22:7262–7264.
Kurrey N, Jalgaonkar S, Joglekar A et al (2009) Snail and Slug mediate radio- and chemo-resistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 27(9):2059–2068.
Kusumbe A, Bapat S (2009) Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Res 69(24):9245–9253.
Kusumbe A, Mali A, Bapat S (2009) CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature. Stem Cells 27:498–508.
Kyritsis A, Tsokos M, Triche T et al (1984) Retinoblastoma – origin from a primitive neuroectodermal cell? Nature 307:471–473.
Lapidot T, Sirard C, Vormoor J et al (1994) A cell initiating human acute myeloid leukaemia after transplantation into scid mice. Nature 367:645–648.
Larderet G, Fortunel N, Vaigot P et al (2006) Human side population keratinocytes exhibit long-term proliferative potential and a specific gene expression profile and can form a pluristratified epidermis. Stem Cells 24:965–974.
Laurie N, Donovan S, Shih C et al (2006) Inactivation of the p53 pathway in retinoblastoma. Nature 444:61–66.
Li C, Heidt D, Dalerba P et al (2007) Identification of pancreatic cancer stem cells. Cancer Res 67:1030–1037.
Mani S, Guo W, Liao M et al (2008) The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 133:704–715.
Mark B, Meads R, Dalton G (2009) Environment-mediated drug resistance: A major contributor to minimal residual disease. Nat Rev Cancer 9:665–67.
Matsui W, Huff C, Wang Q et al (2004) Characterization of clonogenic multiple myeloma cells. Blood 103:2332–2336.
Messmer E, Font R, Kirkpatrick J et al (1985) Immunohistochemical demonstration of neuronal and astrocytic differentiation in retinoblastoma. Ophthalmology 92:167–173.
Mohan A, Kandalam M, Ramkumar H et al (2006) Stem cell markers: Abcg2 and mcm2 expression in retinoblastoma. Br J Ophthalmol 90:889–893.
Molnar M, Stefansson K, Marton L et al (1984) Immunohistochemistry of retinoblastomas in humans. Am J Ophthalmol 97:301–307.
Moore K, Lemischka I (2006) Stem cells and their niches. Science 311:1880–1885.
Moore M (1991) Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 78:1–19.
Mukai N, Kobayashi S (1973) Human adenovirus-induced medulloepitheliomatous neoplasms in sprague-dawley rats. Am J Pathol 73:671–690.
Nakajima T, Kato K, Kaneko A et al (1986) High concentrations of enolase, alpha- and gamma-subunits, in the aqueous humor in cases of retinoblastoma. Am J Ophthalmol 101:102–106.
Nowell P (1976) The clonal evolution of tumor cell populations. Science 194:23–28.
ÓBrien C, Pollett A, Gallinger S et al (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106–110.
Ogawa K, Hamaya K, Fujii Y et al (1969) Tumor induction by adenovirus type 12 and its target cells in the central nervous system. Gann 60:383–392.
Ogawa K, Tsutsumi A, Iwata K et al (1966) Histogenesis of malignant neoplasm induced by adenovirus type 12. Gann 57:43–52.
Ogawa M, Bergsagel D, McCulloch E (1973) Chemotherapy of mouse myeloma: Quantitative cell cultures predictive of response in vivo. Blood 41:7–15.
Pacal M, Bremner R (2006) Insights from animal models on the origins and progression of retinoblastoma. Curr Mol Med 6:759–781.
Park C, Amare M, Savin M (1980) Prediction of chemotherapy response in human leukemia using an in vitro chemotherapy sensitivity test on the leukemic colony-forming cells. Blood 55:595–601.
Pece S, Tosoni D, Confalonieri S et al (2010) Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140(1):62–73.
Peeters S, van der Kolk D, de Haan G et al (2006) Selective expression of cholesterol metabolism genes in normal CD34 + CD38− cells with a heterogeneous expression pattern in aml cells. Exp Hematol 34:622–630.
Perentes E, Herbort C, Rubinstein L et al (1987) Immunohistochemical characterization of human retinoblastomas in situ with multiple markers. Am J Ophthalmol 1987; 103:647–658.
Prince M, Sivanandan R, Kaczorowski A et al (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104:973–978.
Puck T, Marcus P (1956) Action of x-rays on mammalian cells. J Exp Med 103:653–666.
Puck T, Marcus P, Cieciura S (1956) Clonal growth of mammalian cells in vitro; growth characteristics of colonies from single Hela cells with and without a feeder layer. J Exp Med 103:273–283.
Rask K, Nilsson A, Brannstrom M et al (2003) Wnt-signalling pathway in ovarian epithelial tumours: Increased expression of beta-catenin and gsk3beta. Br J Cancer 89:1298–1304.
Reid T, Albert D, Rabson A et al (1974) Characteristics of an established cell line of retinoblastoma. J Natl Cancer Inst 53:347–360.
Reya T, Morrison S, Clarke M et al (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105–111.
Ricci-Vitiani L, Lombardi D, Pilozzi E et al (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445:111–115.
Rodrigues M, Wilson M, Wiggert B et al (1986) Retinoblastoma. A clinical, immunohistochemical, and electron microscopic case report. Ophthalmology 93:1010–1015.
S CR (1994) Pathologic basis of disease. 5th edn. WB Saunders Company, USA.
Sanchez P, Clement V, Ruizi Altaba A (2005) Therapeutic targeting of the hedgehog-gli pathway in prostate cancer. Cancer Res 65:2990–2992.
Sawa H, Takeshita I, Kuramitsu M et al (1987) Immunohistochemistry of retinoblastomas. J Neurooncol 5:351–355.
Scharenberg C, Harkey M, Torok-Storb B (2002) The abcg2 transporter is an efficient hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99:507–512.
Schroder H (1987) Immunohistochemical demonstration of glial markers in retinoblastomas. Virchows Arch A Pathol Anat Histopathol 411:67–72.
Seigel G, Hackam A, Ganguly A et al (2007) Human embryonic and neuronal stem cell markers in retinoblastoma. Mol Vis 13:823–832.
Sery T, Lee E, Lee W et al (1990) Characteristics of two new retinoblastoma cell lines: Weri-rb24 and weri-rb27. J Pediatr Ophthalmol Strabismus 27:212–217.
Setoguchi T, Taga T, Kondo T et al (2004) Cancer stem cells persist in many cancer cell lines. Cell Cycle 3:414–415.
Sieber O, Heinimann K, Tomlinson I (2003) Genomic instability- the engine of tumorigenesis?. Nat Rev Cancer 3:701–708.
Silva A, Yi H, Hayes S et al (2010) Lithium chloride regulates the proliferation of stem-like cells in retinoblastoma cell lines: A potential role for the canonical wnt signaling pathway. Mol Vis16:36–45.
Singh S, Hawkins C, Clarke I et al (2004) Identification of human brain tumour initiating cells. Nature 432:396–401.
Sneddon J, Werb Z (2007) Location, location, location: The cancer stem cell niche. Cell Stem Cell 1:607–611.
Southam C, Brunschwig A (1960) A Quantitative studies of autotransplantation of human cancer. Cancer 14: 971–978.
Suetsugu A, Nagaki M, Aoki H et al (2006) Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 351:820–824.
Summer R, Kotton D, Sun X et al (2003) Side population cells and bcrp1 expression in lung. Am J Physiol Lung Cell Mol Physiol 285:L97–104.
Szotek P, Pieretti-Vanmarcke R, Masiakos P et al (2006) Ovarian cancer side population defines cells with stem cell-like characteristics and mullerian inhibiting substance responsiveness. Proc Natl Acad Sci USA 103:11154–11159.
Terenghi G, Polak J, Ballesta J et al (1984) Immunocytochemistry of neuronal and glial markers in retinoblastoma. Virchows Arch A Pathol Anat Histopathol 404:61–73.
Tumbar T, Guasch G, Greco V et al (2004) Defining the epithelial stem cell niche in skin. Science 303: 359–363.
Umemoto T, Yamato M, Shiratsuchi Y et al (2006) Expression of integrin beta3 is correlated to the properties of quiescent hemopoietic stem cells possessing the side population phenotype. J Immunol 177:7733–7739.
Visvader J, Lindeman G (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8:755–768.
Wani A, Sharma N, Shouche Y et al (2006) Nuclear-mitochondrial genomic profiling reveals a pattern of evolution in epithelial ovarian tumor stem cells. Oncogene 25: 6336–44.
Weaver B, Cleveland D (2007) Aneuploidy: Instigator and inhibitor of tumorigenesis. Cancer Res 67: 10103–10105.
Welm B, Tepera S, Venezia T et al (2002) Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol 245:42–56.
White D, Kurpios N, Zuo D et al (2004) Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 6:159–170.
Wilson A, Radtke F (2006) Multiple functions of notch signaling in self-renewing organs and cancer. FEBS Lett 580:2860–2868.
Windle J, Albert D, ÓBrien J et al (1990) Retinoblastoma in transgenic mice. Nature 343:665–669.
Xu X, Fang Y, Lee T et al (2009) Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific mdm2 signaling. Cell 137:1018–1031.
Yilmaz O, Valdez R, Theisen B et al (2006) Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441:475–482.
Yue Z, Jiang T, Widelitz R et al (2005) Mapping stem cell activities in the feather follicle. Nature 438:1026–1029.
Zagzag D, Krishnamachary B, Yee H et al (2005) Stromal cell-derived factor-1alpha and cxcr4 expression in hemangioblastoma and clear cell-renal cell carcinoma: Von hippel-lindau loss-of-function induces expression of a ligand and its receptor. Cancer Res 65:6178–6188.
Acknowledgements
We thank Dr. G.C. Mishra, Director, National Center for Cell Science (Pune, India) for encouragement and support. We thank Dr Santosh Honavar and team for providing clinical samples for Retinoblastoma work. We also acknowledge the Association for Research in Vision and Ophthalmology, the copyright holder of Figs. 15.3 and 15.4 for permitting use of these figures
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Netherlands
About this chapter
Cite this chapter
Balla, M.M., Kusumbe, A.P., Vemuganti, G.K., Bapat, S.A. (2011). Cancer Stem Cells. In: Steinhoff, G. (eds) Regenerative Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9075-1_15
Download citation
DOI: https://doi.org/10.1007/978-90-481-9075-1_15
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9074-4
Online ISBN: 978-90-481-9075-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)